1. 40K glycoPEGylated, recombinant FVIIa: 3‐month, double‐blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors. Issue 7 (15th July 2013) Authors: Ljung, R.; Karim, F. A.; Saxena, K.; Suzuki, T.; Arkhammar, P.; Rosholm, A.; Giangrande, P. Journal: Journal of thrombosis and haemostasis Issue: Volume 11:Issue 7(2013) Page Start: 1260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline. Issue 4 (30th March 2017) Authors: Hanley, J.; McKernan, A.; Creagh, M. D.; Classey, S.; McLaughlin, P.; Goddard, N.; Briggs, P. J.; Frostick, S.; Giangrande, P.; Wilde, J.; Thachil, J.; Chowdary, P. Journal: Haemophilia Issue: Volume 23:Issue 4(2017) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates. (May 2014) Authors: Giangrande, P.; Seitz, R.; Behr‐Gross, M. E.; Berger, K.; Hilger, A.; Klein, H.; Schramm, W.; Mannucci, P. M. Journal: Haemophilia Issue: Volume 20:Number 3(2014:May) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX. Issue 1 (1st August 2016) Authors: Escobar, M. A.; Tehranchi, R.; Karim, F. A.; Caliskan, U.; Chowdary, P.; Colberg, T.; Giangrande, P.; Giermasz, A.; Mancuso, M. E.; Serban, M.; Tsay, W.; Mahlangu, J. N. Journal: Haemophilia Issue: Volume 23:Issue 1(2017) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Making economic evaluations more helpful for treatment choices in haemophilia. Issue 2 (22nd January 2017) Authors: Drummond, M.; Houwing, N.; Slothuus, U.; Giangrande, P. Journal: Haemophilia Issue: Volume 23:Issue 2(2017) Page Start: e58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices. Issue 6 (27th July 2017) Authors: Neufeld, E. J.; Solimeno, L.; Quon, D.; Walsh, C.; Seremetis, S.; Cooper, D.; Iyer, N. N.; Hoxer, C. S.; Giangrande, P. Journal: Haemophilia Issue: Volume 23:Issue 6(2017) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Research in haemophilia B – approaching the request for high evidence levels in a rare disease. (11th December 2014) Authors: Berger, K.; Schopohl, D.; Hilger, A.; Behr Gross, M. –E.; Giangrande, P.; Peyvandi, F.; Seitz, R.; Schramm, W. Journal: Haemophilia Issue: Volume 21:Number 1(2015:Jan.) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗